Cargando…

Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation

BACKGROUND: Although surgical treatment of residual obstruction after alcohol septal ablation (ASA) is often challenging in patients with obstructive hypertrophic cardiomyopathy (OHCM) there are very few relevant clinical reports. Thus, outcomes of surgical septal myectomy (SSM) in this subgroup of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Qiulan, Zhu, Changsheng, Cui, Hao, Tang, Bing, Wang, Shengwei, Yu, Qinjun, Zhao, Shihua, Song, Yunhu, Wang, Shuiyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947546/
https://www.ncbi.nlm.nih.gov/pubmed/33717578
http://dx.doi.org/10.21037/jtd-20-2779
_version_ 1783663252877606912
author Yang, Qiulan
Zhu, Changsheng
Cui, Hao
Tang, Bing
Wang, Shengwei
Yu, Qinjun
Zhao, Shihua
Song, Yunhu
Wang, Shuiyun
author_facet Yang, Qiulan
Zhu, Changsheng
Cui, Hao
Tang, Bing
Wang, Shengwei
Yu, Qinjun
Zhao, Shihua
Song, Yunhu
Wang, Shuiyun
author_sort Yang, Qiulan
collection PubMed
description BACKGROUND: Although surgical treatment of residual obstruction after alcohol septal ablation (ASA) is often challenging in patients with obstructive hypertrophic cardiomyopathy (OHCM) there are very few relevant clinical reports. Thus, outcomes of surgical septal myectomy (SSM) in this subgroup of patients remain to be determined. Therefore, this study aimed to determine the surgical and follow-up outcomes in patients with OHCM exhibiting residual obstruction after ASA. METHODS: We collected case data for 62 patients with OHCM and residual obstruction after ASA who underwent SSM at Fuwai Hospital between January 2002 and June 2019. Propensity score matching with patients having had a myectomy as the only invasive procedure—was conducted in a 1:2 ratio. Echocardiography parameters, surgery results, and follow-up outcomes were compared between the groups. RESULTS: The prior ASA group had a higher incidence of complete atrioventricular block (AVB) and subsequently postoperative permanent pacemaker (PPM) implantation than the primary myectomy group (9.7% vs. 1.6%, P=0.01). Two patients died within 30 days after surgery in the prior ASA group, and one patient died in the primary myectomy group, with an operative mortality rate of 3.2% and 0.8%, respectively (P=0.2). The 5-year event-free survival rate was 86.0% in the prior ASA group (median follow-up period: 3.2 years; mean: 3.9±2.6 years; maximum, 10.6 years) and 88.5% in the primary myectomy group (median follow-up period: 2.4 years; mean 2.8±1.7 years; maximum, 9.1 years) (P=0.2). During follow-up, four of 62 (6.5%) patients in the prior ASA group and one of 124 (0.8%) patients in the primary myectomy group progressed to advanced heart failure (P=0.025). CONCLUSIONS: Patients with OHCM following ASA are at an increased risk of developing AVB after SSM. Their surgical outcomes, and long-term survival rate were satisfactory and, osimilar to those for patients having had a myectomy as the only invasive procedure. In addition, they had an increased risk of advanced heart failure after SSM in the present study.
format Online
Article
Text
id pubmed-7947546
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-79475462021-03-12 Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation Yang, Qiulan Zhu, Changsheng Cui, Hao Tang, Bing Wang, Shengwei Yu, Qinjun Zhao, Shihua Song, Yunhu Wang, Shuiyun J Thorac Dis Original Article BACKGROUND: Although surgical treatment of residual obstruction after alcohol septal ablation (ASA) is often challenging in patients with obstructive hypertrophic cardiomyopathy (OHCM) there are very few relevant clinical reports. Thus, outcomes of surgical septal myectomy (SSM) in this subgroup of patients remain to be determined. Therefore, this study aimed to determine the surgical and follow-up outcomes in patients with OHCM exhibiting residual obstruction after ASA. METHODS: We collected case data for 62 patients with OHCM and residual obstruction after ASA who underwent SSM at Fuwai Hospital between January 2002 and June 2019. Propensity score matching with patients having had a myectomy as the only invasive procedure—was conducted in a 1:2 ratio. Echocardiography parameters, surgery results, and follow-up outcomes were compared between the groups. RESULTS: The prior ASA group had a higher incidence of complete atrioventricular block (AVB) and subsequently postoperative permanent pacemaker (PPM) implantation than the primary myectomy group (9.7% vs. 1.6%, P=0.01). Two patients died within 30 days after surgery in the prior ASA group, and one patient died in the primary myectomy group, with an operative mortality rate of 3.2% and 0.8%, respectively (P=0.2). The 5-year event-free survival rate was 86.0% in the prior ASA group (median follow-up period: 3.2 years; mean: 3.9±2.6 years; maximum, 10.6 years) and 88.5% in the primary myectomy group (median follow-up period: 2.4 years; mean 2.8±1.7 years; maximum, 9.1 years) (P=0.2). During follow-up, four of 62 (6.5%) patients in the prior ASA group and one of 124 (0.8%) patients in the primary myectomy group progressed to advanced heart failure (P=0.025). CONCLUSIONS: Patients with OHCM following ASA are at an increased risk of developing AVB after SSM. Their surgical outcomes, and long-term survival rate were satisfactory and, osimilar to those for patients having had a myectomy as the only invasive procedure. In addition, they had an increased risk of advanced heart failure after SSM in the present study. AME Publishing Company 2021-02 /pmc/articles/PMC7947546/ /pubmed/33717578 http://dx.doi.org/10.21037/jtd-20-2779 Text en 2021 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Yang, Qiulan
Zhu, Changsheng
Cui, Hao
Tang, Bing
Wang, Shengwei
Yu, Qinjun
Zhao, Shihua
Song, Yunhu
Wang, Shuiyun
Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation
title Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation
title_full Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation
title_fullStr Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation
title_full_unstemmed Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation
title_short Surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation
title_sort surgical septal myectomy outcome for obstructive hypertrophic cardiomyopathy after alcohol septal ablation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947546/
https://www.ncbi.nlm.nih.gov/pubmed/33717578
http://dx.doi.org/10.21037/jtd-20-2779
work_keys_str_mv AT yangqiulan surgicalseptalmyectomyoutcomeforobstructivehypertrophiccardiomyopathyafteralcoholseptalablation
AT zhuchangsheng surgicalseptalmyectomyoutcomeforobstructivehypertrophiccardiomyopathyafteralcoholseptalablation
AT cuihao surgicalseptalmyectomyoutcomeforobstructivehypertrophiccardiomyopathyafteralcoholseptalablation
AT tangbing surgicalseptalmyectomyoutcomeforobstructivehypertrophiccardiomyopathyafteralcoholseptalablation
AT wangshengwei surgicalseptalmyectomyoutcomeforobstructivehypertrophiccardiomyopathyafteralcoholseptalablation
AT yuqinjun surgicalseptalmyectomyoutcomeforobstructivehypertrophiccardiomyopathyafteralcoholseptalablation
AT zhaoshihua surgicalseptalmyectomyoutcomeforobstructivehypertrophiccardiomyopathyafteralcoholseptalablation
AT songyunhu surgicalseptalmyectomyoutcomeforobstructivehypertrophiccardiomyopathyafteralcoholseptalablation
AT wangshuiyun surgicalseptalmyectomyoutcomeforobstructivehypertrophiccardiomyopathyafteralcoholseptalablation